Detalhe da pesquisa
1.
Seven Strategies to Integrate Equity within Translational Research in Neurology.
Ann Neurol
; 95(3): 432-441, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38270253
2.
Experimental Neurotherapeutics: Surfing the Tidal Wave of New Opportunities.
Ann Neurol
; 93(3): 427-430, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546649
3.
Reference curves of motor function outcomes in young steroid-naïve males with Duchenne muscular dystrophy.
Dev Med Child Neurol
; 66(5): 644-653, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37885269
4.
Episodic Ataxia Type 1: Natural History and Effect on Quality of Life.
Cerebellum
; 22(4): 578-586, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35655106
5.
Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.
JAMA
; 327(15): 1456-1468, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35381069
6.
Long-term efficacy and safety of dichlorphenamide for treatment of primary periodic paralysis.
Muscle Nerve
; 64(3): 342-346, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34129236
7.
Ankle bracing practices in ambulatory, corticosteroid-naive boys with Duchenne muscular dystrophy.
Muscle Nerve
; 61(1): 52-57, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31588574
8.
Guidelines on clinical presentation and management of nondystrophic myotonias.
Muscle Nerve
; 62(4): 430-444, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32270509
9.
Long Exercise Test in Periodic Paralysis: A Bayesian Analysis.
Muscle Nerve
; 59(1): 47-54, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29752813
10.
Correction to: Episodic Ataxia Type 1: Natural History and Effect on Quality of Life.
Cerebellum
; 22(4): 587, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35904745
11.
Review of the Diagnosis and Treatment of Periodic Paralysis.
Muscle Nerve
; 57(4): 522-530, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29125635
12.
Effect of Mexiletine on Muscle Stiffness in Patients With Nondystrophic Myotonia Evaluated Using Aggregated N-of-1 Trials.
JAMA
; 320(22): 2344-2353, 2018 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30535218
13.
In vivo impact of presynaptic calcium channel dysfunction on motor axons in episodic ataxia type 2.
Brain
; 139(Pt 2): 380-91, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26912519
14.
Cystic fibrosis newborn screening: a model for neuromuscular disease screening?
Ann Neurol
; 77(2): 189-97, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25425541
15.
Z-disc-associated, alternatively spliced, PDZ motif-containing protein (ZASP) mutations in the actin-binding domain cause disruption of skeletal muscle actin filaments in myofibrillar myopathy.
J Biol Chem
; 289(19): 13615-26, 2014 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-24668811
16.
Combined N-of-1 trials to investigate mexiletine in non-dystrophic myotonia using a Bayesian approach; study rationale and protocol.
BMC Neurol
; 15: 43, 2015 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25880166
17.
Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation.
Brain
; 137(Pt 4): 1009-18, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24578548
18.
Rare disease centers for periodic paralysis: China versus the United States and United Kingdom.
Muscle Nerve
; 49(2): 171-4, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23893386
19.
Non-dystrophic myotonia: prospective study of objective and patient reported outcomes.
Brain
; 136(Pt 7): 2189-200, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23771340
20.
Factors Associated With Early Motor Function Trajectories in DMD After Glucocorticoid Initiation: Post Hoc Analysis of the FOR-DMD Trial.
Neurology
; 102(10): e209206, 2024 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38710006